Delivery Order SPE2DE24D0021-SPE2D626F89P5
- Not listed
- Fisher Scientific Company L.L.C. has been awarded a delivery order valued at $3,300 for the provision of SOFIA 2 Flu + SARS Antigen Fluorescent diagnostic test kits, with an ultimate completion date of February 17, 2026. This fixed-price contract with economic price adjustment was issued by the Department of Defense's Medical Supply Chain on December 17, 2025, and will be performed at Fisher Scientific's principal facility in Pittsburgh, Pennsylvania. No set-aside designation was applied to this...
- Fisher Scientific Company L.L.C. has been awarded a delivery order valued at $3,300 for the supply of SOFIA 2 FLU + SARS antigen fluorescent diagnostic test kits under a fixed-price contract with economic price adjustment. The award, issued on December 3, 2025, with an ultimate completion date of February 2, 2026, was made by the Department of Defense's Medical Supply Chain. Performance will occur in Pittsburgh, Pennsylvania. This delivery order represents a child contract under a larger...
- Fisher Scientific Company L.L.C. has been awarded a delivery order valued at $1,650 for SOFIA 2 Flu + SARS Antigen Fluorescent diagnostic test kits by the Department of Defense's Medical Supply Chain. This fixed-price contract with economic price adjustment provisions is effective through January 27, 2026, and represents a child order under Fisher Scientific's existing blanket purchase agreement vehicle. No set-aside designation was applied to this award, indicating open competition. The...
- Fisher Scientific Company L.L.C. has been awarded a delivery order valued at $2,750 by the Department of Defense's Medical Supply Chain for SOFIA 2 FLU + SARS antigen fluorescent diagnostic test kits. The contract is structured as a fixed-price delivery order with economic price adjustment provisions and carries an ultimate completion date of March 4, 2026. This award represents a child contract issued under a larger indefinite delivery vehicle and involves no set-aside designation, indicating...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $3,300 on January 6, 2026, for SOFIA 2 Flu + SARS Antigen Fluorescent diagnostic test kits under a fixed-price contract with economic price adjustment provisions. The award, issued by the Department of Defense's Medical Supply Chain, is scheduled for completion by March 5, 2026, and will be performed in Pittsburgh, Pennsylvania. This delivery order represents a child contract under a larger vehicle and was awarded without...
- Fisher Scientific Company L.L.C. has been awarded a delivery order valued at $5.5K for SOFIA 2 Flu + SARS Antigen Fluorescent diagnostic test kits under a fixed-price contract with economic price adjustment provisions. The award, issued on October 28, 2025, with an ultimate completion date of December 26, 2025, supports the Department of Defense's Medical Supply Chain with performance conducted in Pittsburgh, Pennsylvania. This delivery order represents a child contract under a larger...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $2,200 for the provision of SOFIA 2 FLU + SARS antigen fluorescent diagnostic test kits. The contract, awarded on October 29, 2025, with an ultimate completion date of December 29, 2025, operates under a fixed-price structure with economic price adjustment provisions. The award was issued by the Department of Defense's Medical Supply Chain and does not utilize a set-aside designation, indicating open competitive procurement....
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $2,200 by the Department of Defense's Medical Supply Chain on December 4, 2025, for SOFIA 2 Flu + SARS Antigen Fluorescent diagnostic test kits. The contract is a fixed-price delivery order with economic price adjustment provisions and carries an ultimate completion date of February 3, 2026. The award is a child contract under a larger vehicle and required no set-aside designation, indicating open competition. Performance...
- Fisher Scientific Company L.L.C. received a delivery order award (4570407195) from the Department of Defense's Medical Supply Chain on January 6, 2026, for SOFIA 2 Flu + SARS Antigen Fluorescent diagnostic test kits. The contract carries a ceiling value of $5,500 and is structured as a fixed-price delivery order with economic price adjustment provisions. Performance will be completed by March 5, 2026, at Fisher Scientific's principal place of business in Pittsburgh, Pennsylvania. This award...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,650 on November 17, 2025, for SOFIA 2 Flu + SARS Antigen Fluorescent diagnostic test kits. This fixed-price contract with economic price adjustment is a child order under a larger indefinite delivery vehicle and will be performed in Pittsburgh, Pennsylvania, with an ultimate completion date of January 15, 2026. The award was issued by the Department of Defense's Medical Supply Chain, a defense agency supporting military...
- SPE2DE24D0021Indefinite Delivery Contract
- SPE2DE24D0021-SPE2D626F89P5Delivery Order
Fisher Scientific Company L.L.C. has been awarded a delivery order contract valued at $11,000 for the supply of SOFIA 2 Flu + SARS Antigen Fluorescent diagnostic test kits. The contract, awarded January 7, 2026, with an ultimate completion date of March 6, 2026, was issued by the Department of Defense's Medical Supply Chain without a set-aside designation, indicating open competition. The work will be performed in Pittsburgh, Pennsylvania, where Fisher Scientific maintains its principal place of business. This represents a child delivery order under a larger procurement vehicle, reflecting the company's established role as a critical supplier of laboratory equipment, diagnostic products, and medical supplies to federal healthcare operations. Fisher Scientific's award aligns with the Department of Defense Medical Supply Chain's ongoing requirements for diagnostic testing capabilities supporting clinical operations across federal medical facilities. The supplier brings substantial federal contracting experience, including active Indefinite Delivery Vehicles with the Department of Veterans Affairs and General Services Administration Multiple Award Schedule agreements, demonstrating proven capability to deliver specialized laboratory and diagnostic products on a reliable basis. The fixed-price contract with economic price adjustment provisions protects against inflationary impacts while maintaining cost certainty for the government's procurement of these essential diagnostic reagents through the completion date in March 2026.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.0k | 1/6/26 |